Download PDF
Clin Colon Rectal Surg 2004; 17(4): 221-230
DOI: 10.1055/s-2004-836942
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Human Papillomavirus, Condylomata Acuminata, and Anal Neoplasia

George J. Chang1 , Mark L. Welton2
  • 1Department of Surgical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas
  • 2Division of Colon and Rectal Surgery, Department of Surgery, Stanford University, School of Medicine, Stanford, California
Further Information

Publication History

Publication Date:
15 November 2004 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Genital human papillomavirus (HPV) infection is an increasingly common sexually transmitted disease. This virus causes condylomata acuminata and is associated with anal neoplasia. Management options are discussed.

KEYWORDS

Human papillomavirus - condylomata acuminata - anal neoplasia

REFERENCES

  • 1 Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.  Sex Transm Dis. 1999;  26(4 suppl) S2-S7
    PubMedGoogle Scholar
  • 2 Munoz N, Bosch F X, de Sanjose S et al.. Epidemiologic classification of human papillomavirus types associated with cervical cancer.  N Engl J Med. 2003;  348 518-527
    Google Scholar
  • 3 World Health Organization .IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses. Vol 64. Lyons, France; IARC 1995
    Google Scholar
  • 4 Galloway D A. Biology of Human Papillomaviruses. In: Holmes K, Mardh P, Sparling P Sexually Transmitted Diseases. 3rd ed. New York, NY; McGraw-Hill 1999: 335-346
    Google Scholar
  • 5 Richart R M, Masood S, Syrjanen K J et al.. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.  Acta Cytol. 1998;  42 50-58
    PubMedGoogle Scholar
  • 6 Bosch F X, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality.  J Natl Cancer Inst Monographs. 2003;  (31) 3-13
    PubMedGoogle Scholar
  • 7 Cope J, Hildesheim A, Schiffman M et al.. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.  J Clin Microbiol. 1997;  35 2262-2265
    PubMedGoogle Scholar
  • 8 Moscicki A B, Hills N, Shiboski S et al.. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.  JAMA. 2001;  285 2995-3002
    CrossrefPubMedGoogle Scholar
  • 9 Woodman C B, Collins S, Winter H et al.. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.  Lancet. 2001;  357 1831-1836
    CrossrefPubMedGoogle Scholar
  • 10 Ho G YF, Bierman R, Beardsley L, Chang C J, Burk R D. Natural history of cervicovaginal papillomavirus infection in young women.  N Engl J Med. 1998;  338 423-428
    CrossrefPubMedGoogle Scholar
  • 11 Piketty C, Darragh T M, Da Costa M et al.. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse.  Ann Intern Med. 2003;  138 453-459 , Summary for patients in Ann Intern Med 2003;  138 I44
    PubMedGoogle Scholar
  • 12 Jenny C, Verdon M, Siegel N et al.. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men.  Ann Intern Med. 1993;  118 844-849
    PubMedGoogle Scholar
  • 13 Sonnex C, Scholefield J H, Kocjan G et al.. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour.  BMJ. 1991;  303 1243
    PubMedGoogle Scholar
  • 14 Palefsky J M, Holly E A, Ralston M L, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.  J Infect Dis. 1998;  177 361-367
    PubMedGoogle Scholar
  • 15 Scholefield J H, Hickson W G, Smith J H, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process.  Lancet. 1992;  340 1271-1273
    CrossrefPubMedGoogle Scholar
  • 16 Ogunbiyi O A, Scholefield J H, Robertson G, Smith J H, Sharp F, Rogers K. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer.  Obstet Gynecol. 1994;  83 212-216
    PubMedGoogle Scholar
  • 17 Holly E A, Ralston M L, Darragh T M, Greenblatt R M, Jay N, Palefsky J M. Prevalence and risk factors for anal squamous intraepithelial lesions in women.  J Natl Cancer Inst. 2001;  93 843-849
    CrossrefPubMedGoogle Scholar
  • 18 Sohn N, Robilotti J G. The gay bowel syndrome. A review of colonic and rectal conditions in 200 male homosexuals.  Am J Gastroenterol. 1977;  67 478-484
    PubMedGoogle Scholar
  • 19 Koutsky L. Epidemiology of genital human papillomavirus infection.  Am J Med. 1997;  102(5A) 3-8
    PubMedGoogle Scholar
  • 20 Schiffman M H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.  J Natl Cancer Inst. 1992;  84 394-398
    CrossrefPubMedGoogle Scholar
  • 21 Roden R B, Lowy D R, Schiller J T. Papillomavirus is resistant to desiccation.  J Infect Dis. 1997;  176 1076-1079
    PubMedGoogle Scholar
  • 22 Williams T S, Callen J P, Owen L G. Vulvar disorders in the prepubertal female.  Pediatr Ann. 1986;  15 588-589 592-601 604-605
    PubMedGoogle Scholar
  • 23 Swerdlow D B, Salvati E P. Condyloma acuminatum.  Dis Colon Rectum. 1971;  14 226-231
    PubMedGoogle Scholar
  • 24 Abcarian H, Sharon N. Long-term effectiveness of the immunotherapy of anal condyloma acuminatum.  Dis Colon Rectum. 1982;  25 648-651
    PubMedGoogle Scholar
  • 25 Abcarian H, Sharon N. The effectiveness of immunotherapy in the treatment of anal condyloma acuminatum.  J Surg Res. 1977;  22 231-236
    CrossrefPubMedGoogle Scholar
  • 26 Landsberg K, Bear R A. Severe condylomata acuminata in a renal transplant recipient.  Am J Nephrol. 1986;  6 325-326
    PubMedGoogle Scholar
  • 27 Puy-Montbrun T, Denis J, Ganansia R, Mathoniere F, Lemarchand N, Arnous-Dubois N. Anorectal lesions in human immunodeficiency virus-infected patients.  Int J Colorectal Dis. 1992;  7 26-30
    CrossrefPubMedGoogle Scholar
  • 28 Palefsky J M, Holly E A, Ralston M L, Jay N, Berry J M, Darragh T M. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.  AIDS. 1998;  12 495-503
    CrossrefPubMedGoogle Scholar
  • 29 Palefsky J M. Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection.  J Acquir Immune Defic Syndr. 1999;  21(suppl 1) S42-S48
    PubMedGoogle Scholar
  • 30 Goedert J J, Cote T R, Virgo P et al.. Spectrum of AIDS-associated malignant disorders.  Lancet. 1998;  351 1833-1839
    CrossrefPubMedGoogle Scholar
  • 31 Culp O S, Kaplan I W. Condylomata acuminata: two hundred cases treated with podophyllin.  Ann Surg. 1944;  120 251-256
    PubMedGoogle Scholar
  • 32 Beutner K R, Conant M A, Friedman-Kien A E et al.. Patient-applied podofilox for treatment of genital warts.  Lancet. 1989;  1 831-834
    PubMedGoogle Scholar
  • 33 Jensen S L. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata.  Lancet. 1985;  2 1146-1148
    PubMedGoogle Scholar
  • 34 von Krogh G. Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study.  Acta Derm Venereol. 1978;  58 163-168
    PubMedGoogle Scholar
  • 35 Simmons P D. Podophyllin 10% and 25% in the treatment of ano-genital warts. A comparative double-blind study.  Br J Vener Dis. 1981;  57 208-209
    PubMedGoogle Scholar
  • 36 Schlappner O L, Shaffer E A. Anorectal condylomata acuminata: a missed part of the condyloma spectrum.  Can Med Assoc J. 1978;  118 172-173
    PubMedGoogle Scholar
  • 37 Miller R A. Podophyllin.  Int J Dermatol. 1985;  24 491-498
    PubMedGoogle Scholar
  • 38 Karol M D, Conner C S, Watanabe A S, Murphrey K J. Podophyllum: suspected teratogenicity from topical application.  Clin Toxicol. 1980;  16 283-286
    PubMedGoogle Scholar
  • 39 Fisher A A. Severe systemic and local reactions to topical podophyllum resin.  Cutis. 1981;  28 233-236 , 242 passim
    PubMedGoogle Scholar
  • 40 Moher L M, Maurer S A. Podophyllum toxicity: case report and literature review.  J Fam Pract. 1979;  9 237-240
    PubMedGoogle Scholar
  • 41 Montaldi D H, Giambrone J P, Courey N G, Taefi P. Podophyllin poisoning associated with the treatment of condyloma acuminatum: a case report.  Am J Obstet Gynecol. 1974;  119 1130-1131
    PubMedGoogle Scholar
  • 42 Tyring S, Edwards L, Cherry L K et al.. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.  Arch Dermatol. 1998;  134 33-38
    CrossrefPubMedGoogle Scholar
  • 43 Bonnez W, Elswick R K, Bailey-Farchione A et al.. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.  Am J Med. 1994;  96 420-425
    CrossrefPubMedGoogle Scholar
  • 44 Weismann K, Kassis V. Treatment of condyloma acuminatum with 0.5% 5-fluorouracil-solution: a double-blind clinical trial.  Z Hautkr. 1982;  57 810-816
    PubMedGoogle Scholar
  • 45 Stone K M, Becker T M, Hadgu A, Kraus S J. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation.  Genitourin Med. 1990;  66 16-19
    PubMedGoogle Scholar
  • 46 Kraus S J, Stone K M. Management of genital infection caused by human papillomavirus.  Rev Infect Dis. 1990;  12(suppl 6) S620-S632
    PubMedGoogle Scholar
  • 47 Cheng S F, Veenema R J. Topical application of thio-tepa to penile and urethral tumors.  J Urol. 1965;  94 259-262
    PubMedGoogle Scholar
  • 48 Figueroa S, Gennaro A R. Intralesional bleomycin injection in treatment of condyloma acuminatum.  Dis Colon Rectum. 1980;  23 550-551
    PubMedGoogle Scholar
  • 49 Georgala S, Danopoulou I, Katsarou A. Dinitrochlorobenzene treatment of condylomata acuminata.  Australas J Dermatol. 1989;  30 103-105
    PubMedGoogle Scholar
  • 50 Happonen H P, Lassus A, Santalahti J, Forsstrom S, Lassus J. Topical idoxuridine for treatment of genital warts in males. A double-blind comparative study of 0.25% and 0.5% cream.  Genitourin Med. 1990;  66 254-256
    PubMedGoogle Scholar
  • 51 Friedman-Kien A E, Eron L J, Conant M et al.. Natural interferon alfa for treatment of condylomata acuminata.  JAMA. 1988;  259 533-538
    CrossrefPubMedGoogle Scholar
  • 52 Horowitz B J. Interferon therapy for condylomatous vulvitis.  Obstet Gynecol. 1989;  73 (3 Pt 1) 446-448
    PubMedGoogle Scholar
  • 53 Eron L J, Judson F, Tucker S et al.. Interferon therapy for condylomata acuminata.  N Engl J Med. 1986;  315 1059-1064
    PubMedGoogle Scholar
  • 54 Congilosi S M, Madoff R D. Current therapy for recurrent and extensive anal warts.  Dis Colon Rectum. 1995;  38 1101-1107
    PubMedGoogle Scholar
  • 55 Fleshner P R, Freilich M I. Adjuvant interferon for anal condyloma. A prospective, randomized trial.  Dis Colon Rectum. 1994;  37 1255-1259
    PubMedGoogle Scholar
  • 56 Schonfeld A, Nitke S, Schattner A et al.. Intramuscular human interferon-beta injections in treatment of condylomata acuminata.  Lancet. 1984;  1 1038-1042
    PubMedGoogle Scholar
  • 57 [No authors listed] . Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial.Comdylomata International Collaborative Study Group.  Acta Derm Venereol. 1993;  73 223-226
    PubMedGoogle Scholar
  • 58 Mayeaux E J, Harper M B, Barksdale W, Pope J B. Noncervical human papillomavirus genital infections.  Am Fam Physician. 1995;  52 1137-1146 1149-1150
    PubMedGoogle Scholar
  • 59 Rockley P F, Tyring S K. Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections.  Pharmacol Ther. 1995;  65 265-287
    CrossrefPubMedGoogle Scholar
  • 60 Douglas J M, Rogers M, Judson F N. The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha 2 interferon.  J Infect Dis. 1986;  154 331-334
    PubMedGoogle Scholar
  • 61 Skinner Jr R B. Imiquimod.  Dermatol Clin. 2003;  21 291-300
    PubMedGoogle Scholar
  • 62 Biberstein H. Immunization therapy of warts.  Arch Dermatol Syphilol. 1944;  50 12-22
    PubMedGoogle Scholar
  • 63 Breitburd F, Coursaget P. Human papillomavirus vaccines.  Semin Cancer Biol. 1999;  9 431-444
    CrossrefPubMedGoogle Scholar
  • 64 Berry J M, Palefsky J M. A review of human papillomavirus vaccines: from basic science to clinical trials.  Front Biosci. 2003;  8 s333-s345
    CrossrefPubMedGoogle Scholar
  • 65 Baggish M S. Carbon dioxide laser treatment for condylomata acuminata venereal infections.  Obstet Gynecol. 1980;  55 711-715
    PubMedGoogle Scholar
  • 66 Billingham R P, Lewis F G. Laser versus electrical cautery in the treatment of condylomata acuminata of the anus.  Surg Gynecol Obstet. 1982;  155 865-867
    PubMedGoogle Scholar
  • 67 Dixon J A, Gilbertson J J. Cutaneous laser therapy.  West J Med. 1985;  143 758-763
    PubMedGoogle Scholar
  • 68 Duus B R, Philipsen T, Christensen J D, Lundvall F, Sondergaard J. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment.  Genitourin Med. 1985;  61 59-61
    PubMedGoogle Scholar
  • 69 Ferenczy A, Bergeron C, Richart R M. Human papillomavirus DNA in CO2 laser-generated plume of smoke and its consequences to the surgeon.  Obstet Gynecol. 1990;  75 114-118
    PubMedGoogle Scholar
  • 70 Garden J M, O'Banion M K, Shelnitz L S et al.. Papillomavirus in the vapor of carbon dioxide laser-treated verrucae.  JAMA. 1988;  259 1199-1202
    CrossrefPubMedGoogle Scholar
  • 71 Hallmo P, Naess O. Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon.  Eur Arch Otorhinolaryngol. 1991;  248 425-427
    CrossrefPubMedGoogle Scholar
  • 72 Godley M J, Bradbeer C S, Gellan M, Thin R N. Cryotherapy compared with trichloroacetic acid in treating genital warts.  Genitourin Med. 1987;  63 390-392
    PubMedGoogle Scholar
  • 73 Simmons P D, Langlet F, Thin R N. Cryotherapy versus electrocautery in the treatment of genital warts.  Br J Vener Dis. 1981;  57 273-274
    PubMedGoogle Scholar
  • 74 Thomson J P, Grace R H. The treatment of perianal and anal condylomata acuminata: a new operative technique.  J R Soc Med. 1978;  71 180-185
    PubMedGoogle Scholar
  • 75 Khawaja H T. Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study.  Br J Surg. 1989;  76 1067-1068
    PubMedGoogle Scholar
  • 76 Hoyme U B, Hagedorn M, Schindler A E et al.. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.  Infect Dis Obstet Gynecol. 2002;  10 79-88
    PubMedGoogle Scholar
  • 77 Division of STD prevention. Prevention of Genital HPV Infection and Sequelae: Report of an External Consultants' Meeting December 1999 Atlanta, GA; Available at: www.cdc.gov/nchstp/dstd/Reports-publication/99Hpr
    Google Scholar
  • 78 Frisch M, Glimelius B, van den Brule A JC et al.. Sexually transmitted infection as a cause of anal cancer.  N Engl J Med. 1997;  337 1350-1358
    CrossrefPubMedGoogle Scholar
  • 79 Schiffman M H, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.  J Natl Cancer Inst. 2003;  95 E2
    PubMedGoogle Scholar
  • 80 Chang G J, Welton M L. Anal neoplasia.  Sem Colon Rectal Surg. 2003;  14 111-118
    PubMedGoogle Scholar
  • 81 Critchlow C W, Hawes S E, Kuypers J M et al.. Effect of HIV infection on the natural history of anal human papillomavirus infection.  AIDS. 1998;  12 1177-1184
    CrossrefPubMedGoogle Scholar
  • 82 Goldie S J, Kuntz K M, Weinstein M C, Freedberg K A, Palefsky J M. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.  Am J Med. 2000;  108 634-641
    CrossrefPubMedGoogle Scholar
  • 83 Goldie S J, Kuntz K M, Weinstein M C, Freedberg K A, Welton M L, Palefsky J M. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.  JAMA. 1999;  281 1822-1829
    CrossrefPubMedGoogle Scholar
  • 84 Litle V R, Leavenworth J D, Darragh T M et al.. Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions.  Dis Colon Rectum. 2000;  43 346-352
    PubMedGoogle Scholar
  • 85 Duggan M A. A review of the natural history of cervical intraepithelial neoplasia.  Gan to Kagaku Ryoho [Japanese Journal of Cancer & Chemotherapy]. 2002;  29(suppl 1) 176-193
    PubMedGoogle Scholar
  • 86 Palefsky J M, Holly E A, Hogeboom C J et al.. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;  17 314-319
    CrossrefPubMedGoogle Scholar
  • 87 Sobhani I, Vuagnat A, Walker F et al.. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals.  , [comment] Gastroenterology. 2001;  120 857-866
    CrossrefPubMedGoogle Scholar
  • 88 Critchlow C W, Surawicz C M, Holmes K K et al.. Prospective study of high-grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection.  AIDS. 1995;  9 1255-1262
    CrossrefPubMedGoogle Scholar
  • 89 Strauss R J, Fazio V W. Bowen's disease of the anal and perianal area. A report and analysis of twelve cases.  Am J Surg. 1979;  137 231-234
    CrossrefPubMedGoogle Scholar
  • 90 Marchesa P, Fazio V W, Oliart S, Goldblum J R, Lavery I C. Perianal Bowen's disease: a clinicopathologic study of 47 patients.  Dis Colon Rectum. 1997;  40 1286-1293
    CrossrefPubMedGoogle Scholar
  • 91 Marfing T E, Abel M E, Gallagher D M. Perianal Bowen's disease and associated malignancies. Results of a survey.  Dis Colon Rectum. 1987;  30 782-785
    PubMedGoogle Scholar
  • 92 Welton M L, Leavenworth J D, Litle V R et al.. Perianal Bowen's disease and anal high grade squamous intraepithelial lesions (HSIL) are histologically and immunohistochemically indistinguishable. Paper presented at: Annual Meeting of the American Society of Colon and Rectal Surgeons; June 3-7 2001 San Diego, CA
  • 93 Chang G J, Berry J M, Jay N, Palefsky J M, Welton M L. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study.  Dis Colon Rectum. 2002;  45 453-458
    CrossrefPubMedGoogle Scholar
  • 94 Jay N, Berry J M, Hogeboom C J, Holly E A, Darragh T M, Palefsky J M. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology.  Dis Colon Rectum. 1997;  40 919-928
    CrossrefPubMedGoogle Scholar

George J ChangM.D. 

Department of Surgical Oncology, Unit 444, U.T. M.D. Anderson Cancer Center

1400 Holcombe Blvd, FC 12.3004

Houston, TX 77230-1402

Email: gchang@mdanderson.org